Get the Stockscreener App
0.632
4.90%
0.0295
Xortx Therapeutics Inc stock is traded at $0.632, with a volume of 761.91K.
It is up +4.90% in the last 24 hours and down -21.00% over the past month.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
See More
Previous Close:
$0.6025
Open:
$0.61
24h Volume:
761.91K
Relative Volume:
0.41
Market Cap:
$3.24M
Revenue:
-
Net Income/Loss:
$-736.70K
P/E Ratio:
-63.20
EPS:
-0.01
Net Cash Flow:
$-4.14M
1W Performance:
-4.60%
1M Performance:
-21.00%
6M Performance:
-37.43%
1Y Performance:
-55.80%
1-Day Range:
$0.5724
$0.70
1-Week Range:
$0.5724
$0.73
52-Week Range:
$0.5724
$1.79
Xortx Therapeutics Inc Stock (XRTX) Company Profile
Compare XRTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XRTX
Xortx Therapeutics Inc
|
0.622 | 3.49M | 0 | -736.70K | -4.14M | -0.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.52 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.42 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.79 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.21 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.05 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Xortx Therapeutics Inc Stock (XRTX) Latest News
Is XORTX Therapeutics Inc. (ANUA) stock testing key support2025 Sector Review & AI Powered Market Entry Ideas - newser.com
Chart based exit strategy for XORTX Therapeutics Inc.July 2025 Selloffs & Consistent Income Trade Ideas - newser.com
Is XORTX Therapeutics Inc. stock cheap at current valuation2025 Earnings Impact & Reliable Breakout Stock Forecasts - newser.com
Heatmap analysis for XORTX Therapeutics Inc. and competitorsJuly 2025 WrapUp & Free Long-Term Investment Growth Plans - newser.com
Will XORTX Therapeutics Inc. stock benefit from commodity prices2025 Fundamental Recap & Technical Buy Zone Confirmations - newser.com
Is XORTX Therapeutics Inc. (ANUA) stock attractive for growth fundsJuly 2025 Opening Moves & Short-Term High Return Ideas - newser.com
Can XORTX Therapeutics Inc. (ANUA) stock beat analyst consensusJuly 2025 Volume & Smart Allocation Stock Reports - newser.com
Published on: 2025-11-03 02:59:46 - newser.com
Is XORTX Therapeutics Inc. forming a bottoming base2025 Bull vs Bear & Reliable Price Breakout Signals - newser.com
Statistical indicators supporting XORTX Therapeutics Inc.’s strengthJuly 2025 Volume & Technical Entry and Exit Tips - newser.com
Can XORTX Therapeutics Inc. stock sustain revenue growthProduct Launch & Safe Entry Trade Signal Reports - newser.com
Predicting XORTX Therapeutics Inc. trend using moving averagesPortfolio Update Report & Free Expert Verified Stock Movement Alerts - newser.com
Is XORTX Therapeutics Inc. stock entering bullish territoryCPI Data & Free Community Supported Trade Ideas - newser.com
How to build a custom watchlist for XORTX Therapeutics Inc.Market Growth Report & Detailed Earnings Play Alerts - newser.com
What data driven models say about XORTX Therapeutics Inc.’s futureWeekly Trade Recap & Verified Swing Trading Watchlists - newser.com
How XORTX Therapeutics Inc. (ANUA) stock reacts to stronger dollarPortfolio Performance Summary & High Accuracy Buy Signal Tips - newser.com
XORTX Therapeutics Inc. (XRTX) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Can XORTX Therapeutics Inc. stock attract ESG capital inflowsPortfolio Gains Summary & Safe Capital Growth Trade Ideas - newser.com
XORTX Therapeutics Completes $1.1 Million Direct Offering - MSN
Is XORTX Therapeutics Inc. trending in predictive chart modelsEarnings Trend Report & Stepwise Trade Execution Plans - newser.com
Will XORTX Therapeutics Inc. stock see insider buyingJuly 2025 Price Swings & Weekly Breakout Stock Alerts - newser.com
Will XORTX Therapeutics Inc. bounce back from current support2025 Retail Activity & Target Return Focused Stock Picks - newser.com
Will XORTX Therapeutics Inc. stock gain from government policiesMarket Performance Recap & Weekly Stock Performance Updates - newser.com
Form 6-KReport of foreign issuer [Rules 13a-16 and 15d-16] - ADVFN
Order flow analysis tools used on XORTX Therapeutics Inc.Bull Run & Entry Point Confirmation Alerts - newser.com
Can XORTX Therapeutics Inc. stock reach $100 price targetMarket Sentiment Review & Free Safe Entry Trade Signal Reports - newser.com
XORTX Therapeutics Inc Stock Analysis and ForecastAnalyst Downgrades & Get Tomorrow’s Winners Today With AI - earlytimes.in
Vectus Biosystems Advances Strategic Partnerships and Licensing Opportunities - TipRanks
XORTX Therapeutics files to sell up to 4.76M shares - MSN
Xortx Therapeutics Inc Stock (XRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):